These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 12013364

  • 21. Atypical neuroleptic malignant syndrome - A case report.
    Vellekkatt F, Kuppili PP, Bharadwaj B, Menon V.
    Asian J Psychiatr; 2019 Jun; 43():7-8. PubMed ID: 31071486
    [Abstract] [Full Text] [Related]

  • 22. Atypical antipsychotics and neuroleptic malignant syndrome.
    Kohen D, Bristow MF.
    Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
    [No Abstract] [Full Text] [Related]

  • 23. Possible neuroleptic malignant syndrome associated with olanzapine.
    Nyfort-Hansen K, Alderman CP.
    Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
    [No Abstract] [Full Text] [Related]

  • 24. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 25. Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis.
    Finkel B, Lerner A, Oyffe I, Rudinski D, Sigal M, Weizman A.
    Int Clin Psychopharmacol; 1998 May; 13(3):133-5. PubMed ID: 9690981
    [Abstract] [Full Text] [Related]

  • 26. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A, Schumacher J, Abdalla E, LePage J, McGhee M, Butcher D, Griffin H, Shahda M.
    W V Med J; 2002 May; 98(2):63-5. PubMed ID: 12048741
    [Abstract] [Full Text] [Related]

  • 27. Olanzapine and NMS.
    Hickey C, Stewart C, Lippmann S.
    Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
    [No Abstract] [Full Text] [Related]

  • 28. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
    Mishra B, Mishra B, Sahoo S, Arora M, Khess CR.
    Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
    [Abstract] [Full Text] [Related]

  • 29. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS, Lindsay S, Strawn JR, Kaneria RM, Patel NC, Keck PE.
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [Abstract] [Full Text] [Related]

  • 30. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
    Abu-Kishk I, Toledano M, Reis A, Daniel D, Berkovitch M.
    J Toxicol Clin Toxicol; 2004 Apr; 42(6):921-5. PubMed ID: 15533033
    [Abstract] [Full Text] [Related]

  • 31. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J, Bruhn AM.
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [Abstract] [Full Text] [Related]

  • 32. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
    Gram LF.
    Ugeskr Laeger; 2000 Mar 27; 162(13):1914-5. PubMed ID: 10765710
    [No Abstract] [Full Text] [Related]

  • 33. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V, Bruxner G.
    Aust N Z J Psychiatry; 1998 Dec 27; 32(6):884-6. PubMed ID: 10084355
    [Abstract] [Full Text] [Related]

  • 34. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
    Chungh DS, Kim BN, Cho SC.
    J Psychopharmacol; 2005 Jul 27; 19(4):422-5. PubMed ID: 15982999
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
    Stevens DL, Lee MR, Padua Y.
    Pharmacotherapy; 2008 Mar 27; 28(3):403-5. PubMed ID: 18294120
    [Abstract] [Full Text] [Related]

  • 37. Neuropletic malignant syndrome and olanzapine.
    Sierra-Biddle D, Herran A, Diez-Aja S, Gonzalez-Mata JM, Vidal E, Diez-Manrique F, Vazquez-Barquero JL.
    J Clin Psychopharmacol; 2000 Dec 27; 20(6):704-5. PubMed ID: 11106147
    [No Abstract] [Full Text] [Related]

  • 38. Tardive dystonia associated with olanzapine therapy.
    Gunal DI, Onultan O, Afsar N, Aktan S.
    Neurol Sci; 2001 Aug 27; 22(4):331-2. PubMed ID: 11808858
    [Abstract] [Full Text] [Related]

  • 39. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R, Gibson B, Procyshyn RM, Kang N.
    Int J Geriatr Psychiatry; 2002 Apr 27; 17(4):326-8. PubMed ID: 11994885
    [Abstract] [Full Text] [Related]

  • 40. Possible neuroleptic malignant syndrome associated with paliperidone.
    Duggal HS.
    J Neuropsychiatry Clin Neurosci; 2007 Apr 27; 19(4):477-8. PubMed ID: 18070861
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.